Patient Demographics
| Demographic | All patients (n = 305) | Percentage |
| Sex | ||
| Male | 210 | 68.9% |
| Female | 95 | 31.1% |
| Age (y) | 0.4–18 | |
| HL | 219 | 71.8% |
| Classic | 213 | 69.8% |
| Nodular lymphocyte predominant | 6 | 2.0% |
| NHL | 86 | 28.2% |
| Burkitt | 43 | 14.1% |
| DLBCL | 19 | 6.2% |
| T cell | 6 | 2.0% |
| Primary B cell | 5 | 1.6% |
| Anaplastic | 13 | 4.3% |
| Stage (HL & NHL) | ||
| 1 | 50 | 16.4% |
| 2 | 95 | 31.1% |
| 3 | 79 | 25.9% |
| 4 | 81 | 26.6% |
| Country | ||
| Bangladesh | 11 | 3.6% |
| Brazil (Curitiba) | 24 | 7.9% |
| Brazil (Campinas) | 21 | 6.9% |
| Canada | 28 | 9.2% |
| United Kingdom | 11 | 3.6% |
| India (New Delhi) | 59 | 19.3% |
| India (Mumbai) | 75 | 24.6% |
| Israel | 25 | 8.2% |
| Pakistan | 16 | 5.2% |
| South Africa | 7 | 2.3% |
| Uruguay | 28 | 9.2% |
| Bulky disease (>5 cm) | 171 | 56.1% |
| B symptoms | 128 | |
| Bone marrow involvement | 87 | 28.5% |
| Extranodal disease | 95 | 31.1% |
| Spleen disease | 87 | 28.5% |